The IRE1α-XBP1 axis was also shown to be crucial in the tumor antigen cross-presentation of CD8α+ conventional DCs, and deficiency of XBP1 in CD8α+ DCs resulted in a defective phenotype and antigen-presenting capacity [18]. This evidence concerns the gene CD8A and neoplasm.